Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 16376520)

1.

Regulation of cellular functions by the ERK5 signalling pathway.

Wang X, Tournier C.

Cell Signal. 2006 Jun;18(6):753-60. Epub 2006 Jan 6. Review.

PMID:
16376520
2.

Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.

Gavine PR, Wang M, Yu D, Hu E, Huang C, Xia J, Su X, Fan J, Zhang T, Ye Q, Zheng L, Zhu G, Qian Z, Luo Q, Hou YY, Ji Q.

BMC Cancer. 2015 Jun 4;15:454. doi: 10.1186/s12885-015-1455-y.

3.

Platelet ERK5 is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion.

Cameron SJ, Ture SK, Mickelsen D, Chakrabarti E, Modjeski KL, McNitt S, Seaberry M, Field DJ, Le NT, Abe JI, Morrell CN.

Circulation. 2015 May 1. pii: CIRCULATIONAHA.115.015656. [Epub ahead of print]

PMID:
25934838
4.

ERK5 Mediated Signalling in Diabetic Retinopathy.

Wu Y, Chakrabarti S.

Med Hypothesis Discov Innov Ophthalmol. 2015 Spring;4(1):17-26. Review.

5.

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments.

Miranda M, Rozali E, Khanna KK, Al-Ejeh F.

Oncoscience. 2015 Feb 20;2(2):99-101. eCollection 2015.

6.

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

Simões AE, Pereira DM, Gomes SE, Brito H, Carvalho T, French A, Castro RE, Steer CJ, Thibodeau SN, Rodrigues CM, Borralho PM.

Cell Death Dis. 2015 Apr 9;6:e1718. doi: 10.1038/cddis.2015.83.

PMID:
25855966
7.

The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.

Wang X, Pesakhov S, Harrison JS, Kafka M, Danilenko M, Studzinski GP.

Exp Cell Res. 2015 Jan 1;330(1):199-211. doi: 10.1016/j.yexcr.2014.10.003. Epub 2014 Oct 16.

PMID:
25447310
8.

The role of ERK5 in endothelial cell function.

Nithianandarajah-Jones GN, Wilm B, Goldring CE, Müller J, Cross MJ.

Biochem Soc Trans. 2014 Dec;42(6):1584-9. doi: 10.1042/BST20140276.

PMID:
25399574
9.

Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.

Takeda AN, Oberoi-Khanuja TK, Glatz G, Schulenburg K, Scholz RP, Carpy A, Macek B, Remenyi A, Rajalingam K.

EMBO J. 2014 Aug 18;33(16):1784-801. doi: 10.15252/embj.201487808. Epub 2014 Jun 28.

PMID:
24975362
10.

[Roles of ERK5 in neuronal cells].

Obara Y, Ishii K.

Nihon Yakurigaku Zasshi. 2013 Jun;141(6):354. Review. Japanese. No abstract available.

PMID:
23749078
11.

[Roles of ERK5 in neuronal cells].

Obara Y.

Nihon Yakurigaku Zasshi. 2013 May;141(5):251-5. Review. Japanese. No abstract available.

PMID:
23665555
12.

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer.

Ahmad I, Singh LB, Yang ZH, Kalna G, Fleming J, Fisher G, Cooper C, Cuzick J, Berney DM, Møller H, Scardino P, Leung HY.

Br J Cancer. 2013 Jan 15;108(1):149-54. doi: 10.1038/bjc.2012.510.

13.

ERK5: structure, regulation and function.

Nithianandarajah-Jones GN, Wilm B, Goldring CE, Müller J, Cross MJ.

Cell Signal. 2012 Nov;24(11):2187-96. doi: 10.1016/j.cellsig.2012.07.007. Epub 2012 Jul 16. Review.

PMID:
22800864
14.

Extracellular-regulated-kinase 5-mediated renal protection against ischemia-reperfusion injury.

Kawakami T, Park SW, Kaku R, Yang J.

Biochem Biophys Res Commun. 2012 Feb 24;418(4):603-8. doi: 10.1016/j.bbrc.2012.01.043. Epub 2012 Jan 24.

15.

ERK5 and its role in tumour development.

Lochhead PA, Gilley R, Cook SJ.

Biochem Soc Trans. 2012 Feb;40(1):251-6. doi: 10.1042/BST20110663. Review.

PMID:
22260700
16.

MEK5/ERK5 pathway: the first fifteen years.

Drew BA, Burow ME, Beckman BS.

Biochim Biophys Acta. 2012 Jan;1825(1):37-48. doi: 10.1016/j.bbcan.2011.10.002. Epub 2011 Oct 13. Review.

17.

Cytoskeletal reorganization mediates fluid shear stress-induced ERK5 activation in osteoblastic cells.

Li P, Ma YC, Shen HL, Han H, Wang J, Cheng HJ, Wang CF, Xia YY.

Cell Biol Int. 2012 Mar 1;36(3):229-36. doi: 10.1042/CBI20110113.

PMID:
21954859
18.

Targeting the BMK1 MAP kinase pathway in cancer therapy.

Yang Q, Lee JD.

Clin Cancer Res. 2011 Jun 1;17(11):3527-32. doi: 10.1158/1078-0432.CCR-10-2504. Epub 2011 Mar 8.

19.

Activation of the spinal extracellular signal-regulated kinase 5 signaling pathway contributes to morphine physical dependence in rats.

Wang CG, Lu XF, Wei JQ, Liu H, Zhang HX, Zhang LC, Cao JL.

Neurosci Lett. 2011 Apr 20;494(1):38-43. doi: 10.1016/j.neulet.2011.02.049. Epub 2011 Feb 25.

PMID:
21356274
20.

ERK5 signalling in prostate cancer promotes an invasive phenotype.

Ramsay AK, McCracken SR, Soofi M, Fleming J, Yu AX, Ahmad I, Morland R, Machesky L, Nixon C, Edwards DR, Nuttall RK, Seywright M, Marquez R, Keller E, Leung HY.

Br J Cancer. 2011 Feb 15;104(4):664-72. doi: 10.1038/sj.bjc.6606062. Epub 2011 Jan 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk